Trial Profile
A Clinical Trial for Evaluation of Adequate Dose and Safety of DW-3102 in Hypercholesterolemia Patients
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Oct 2018
Price :
$35
*
At a glance
- Drugs DW 3102 (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Daewon Pharmaceutical
- 26 Feb 2015 New trial record